Phase 1 study of irinotecan (CPT-11) in patients with abnormal liver or renal function or with prior pelvic radiation therapy

---

Autoria(s): Venook, A.; Klein, C.; Kastrissios, H.; Leichman, C.; Hollis, D.; Hohl, R.; Villalona, M.; Ratain, M. J.

Data(s)	01/01/2001
Identificador	http://espace.library.uq.edu.au/view/UQ:96177
Idioma(s)	eng
Publicador	American Society of Clinical Oncology
Palavras-Chave	#EX #320503 Clinical Pharmacology and Therapeutics #730108 Cancer and related disorders
Tipo	Conference Paper